Traumatic brain injury (TBI) affects millions globally, leaving many with debilitating long-term consequences. Current treatment options are limited, focusing primarily on symptom management. But what if a simple nasal spray could offer a new path to recovery? A groundbreaking study published in Nature Neuroscience reveals the potential of Foralumab, a nasally administered anti-CD3 monoclonal ..
